NCT00764673

The 3DKnee™ System: A Post-Market Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 71 (actual)
• Sponsor: Encore Medical, L.P. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the survivorship and efficacy of the Encore 3DKnee™ system in a group of patients who will receive the 3DKnee™ as a primary (first) orthopedic implant in the knee. Each knee will be designated as a separate subject and followed for a period of 2 years.

Conditions

• Osteoarthritis
• Rheumatoid Arthritis
• Post Traumatic Arthritis
• Varus Deformity
• Avascular Necrosis

Interventions

Type	Name	Description
DEVICE	3DKnee	Subjects with knee osteoarthritis and willing to participate in the study

Timeline

• Start date: 2006-10-01
• Primary completion: 2010-10-01
• Completion: 2010-10-01
• First posted: 2008-10-02
• Last updated: 2011-03-02
• Results posted: 2011-03-02

Locations

1 site across 1 country: United States